Gene Logic, Genstruct Partner on Toxicology Screening | GenomeWeb

NEW YORK (GenomeWeb News) — Gene Logic and Genstruct will partner in an effort to market screening technologies that their pharmaceutical clients could use to test the potential toxicity of various compounds, the firms said today in a joint statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.